Study IDs key protein for cell death
Findings may offer a new way to kill cancer cells by forcing them into an alternative programmed-death pathway.
A different view of cancer cells
New study measures physical changes in tumor cells as they become metastatic.
Study reveals how melanoma evades chemotherapy
Drugs that block nitric oxide could weaken cancer cells’ resistance, researchers say.
How to minimize the side effects of cancer treatment
Measuring enzyme levels in patients may reveal healthy cells’ ability to survive chemotherapy.
Practicing medicine at the nanoscale
New approaches to drug delivery offer hope for new, more targeted treatments.
Research update: Chemists find help from nature in fighting cancer
Study of several dozen compounds based on a fungal chemical shows potent anti-tumor activity.
Some cancer mutations slow tumor growth
Surprising result suggests that enhancing these mutations’ impact could offer a new way to treat cancer.
Tiny tools help advance medical discoveries
MIT researchers are designing tools to analyze cells at the microscale.
Professor Roger Kamm visualizes sneaky tumor cells with 3-D assay
Kamm is studying the mechanics of metastasis, the process of cancer-cell migration from one location in the body to another and the cause of more than 90 percent of cancer deaths.
Improving the accuracy of cancer diagnoses
New spectroscopy technique could help doctors better identify breast tumors.
New technology may enable earlier cancer diagnosis
Nanoparticles amplify tumor signals, making them much easier to detect in the urine.
Tissue engineering: Growing new organs, and more
Research could lead to better ways to heal injuries and develop new drugs.
On the hunt for rare cancer cells
Jellyfish-inspired device that rapidly and efficiently captures cancer cells from blood samples could enable better patient monitoring.
How cancer cells break free from tumors
New MIT study identifies adhesion molecules key to cancer’s spread through the body.
How better financing could help create new cancer drugs
MIT finance researchers say a diversified ‘megafund’ of securities could help the industry deliver new products to consumers.